Clinical Trials Using Actinium Ac 225 Lintuzumab

Clinical trials are research studies that involve people. The clinical trials on this list are studying Actinium Ac 225 Lintuzumab. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

    The study is a multicenter, open label Phase I / II trial. 1. Establish the MTD of fractionated doses of Lintuzumab-Ac225 in combination with low dose cytosine arabinoside (Low Dose Ara-C, LDAC) (Phase 1 portion) 2. Determine the response rate (CR + CRp + CRi) to fractionated doses of Lintuzumab-Ac225 alone (Phase 2 portion)
    Location: 6 locations